Exemestane 25 mg (Mylan)

Exemestane 25 mg (Mylan)

Active ingredient: Exemestane 25 mg
Dosage form: Film-coated tablets
Pack size: 30 tablets
Manufacturer: Mylan S.A.S. (France)
Route: Oral use

Product description

Exemestane Mylan contains exemestane, a steroidal aromatase inhibitor. In postmenopausal women it lowers the level of endogenous estrogens by blocking their synthesis, which is the basis of its use in hormone-dependent conditions.

The product is manufactured in France by Mylan (Viatris) and is a prescription-only medicine.

Indications

• hormone-dependent breast cancer in postmenopausal women, as prescribed by a physician
• as part of adjuvant and advanced therapy protocols under medical supervision

Dosage and administration

The usual adult dose is 25 mg once daily after a meal. The treatment regimen is determined individually by the treating physician.

Contraindications

• hypersensitivity to exemestane or any excipient
• premenopausal hormonal status
• pregnancy and breastfeeding
• use without medical supervision is not recommended

Storage conditions

Store at a temperature not exceeding 25 °C, in a dry place. Keep out of reach of children.

FAQ

What is Exemestane used for?

It is a hormonal therapy used in postmenopausal women for hormone-dependent breast cancer, as part of treatment protocols prescribed by a physician.

How should it be taken?

The usual dose is 25 mg once daily after a meal. The exact regimen is set by the treating physician.

Do I need a prescription?

Yes. Exemestane is a prescription-only medicine and should be used under medical supervision.

Can men or premenopausal women take it?

No. It is indicated only for postmenopausal hormonal status.

What are the common side effects?

Hot flushes, joint pain, fatigue and nausea may occur. Consult your doctor if symptoms persist.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp